About
Paradigm Biopharmaceuticals Ltd (AU:PAR) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
March 2026 Quarterly Activities Report & Appendix 4C
Mar 31 2026
Paradigm Achieves 50% Patient Dosing in Phase 3
Feb 27 2026
Appendix 4D and Half Year Report
Feb 18 2026
Drawdown of Tranche 3 under the Convertible Note Facility
Feb 11 2026
Published Canine Study Strengthens iPPS Phase 3 Rationale
Google Übersetzer